SOFETABART MIPITECAN

UNII:	E9VWP79J9B
Type:	INGREDIENT SUBSTANCE
Formula:
Preferred Substance Name:	SOFETABART MIPITECAN
GSRS Full Record:	E9VWP79J9B i

3066906-36-0
Immunoglobulin G1 [236-alanine, 237-alanine], anti-(human folate receptor α) (human-Mus musculus monoclonal LSN4170023 γ1-chain), complex with humanMus musculus monoclonal LSN4170023 κ-chain, dimer, octakis(thioether) with N-[(2S)-2-[4-[(N-acetyl-L-valyl-L-alanyl)amino]phenyl]-2-[[[[(1S,9S)-9-ethyl-5-fluoro2,3,9,10,13,15-hexahydro-9-hydroxy-4-methyl-10,13-dioxo-1H,12Hbenzo[de]pyrano[3′,4′:6,7]indolizino[1,2-b]quinolin-1-yl]amino]carbonyl]oxy]ethyl]-N2-[2-[2-[2-[[3-(3-mercapto-2,5-dioxo-1-pyrrolidinyl)-1-oxopropyl]amino]ethoxy]ethoxy]acetyl]-L-glutaminyl-N-methylglycyl-N-methylglycyl-Nmethylglycyl-N-methylglycyl-N-methylglycyl-N-methylglycyl-N-methylglycyl-Nmethylglycyl-N-methylglycyl-N-methylglycine
Immunoglobulin G1-kappa, anti-[Homo sapiens folate receptor 1 (FOLR1, folate receptor alpha, FR-alpha, adult folate-binding protein, FBP, ovarian tumor-associated antigen MOv18)], human monoclonal antibody; gamma1 heavy chain (1-449) [humanized VH (Homo sapiens IGHV3-30*03 (82.70%) -(IGHD)-IGHJ5*01, L123>P) [8.8.12] (1-119) -Homo sapiens IGHG1*01 (120-449)], (222-217')-disulfide with kappa light chain (1'-217') [humanized V-KAPPA (Homo sapiens IGKV1-33*01 (80.20%) -IGKJ2*01, L124>V) [7.3.11] (1'-110') -Homo sapiens IGKC*01 (111'-217')]; (228-228'':231-231'')-bisdisulfide dimer, octakis(thioether) conjugated with N-[(2S)-2-[4-[(Nacetyl-L-valyl-L-alanyl)amino]phenyl]-2-[[[[(1S,9S)-9-ethyl-5-fluoro-2,3,9,10,13,15-hexahydro-9-hydroxy-4-methyl-10,13-dioxo-1H,12Hbenzo[de]pyrano[3′,4′:6,7]indolizino[1,2-b]quinolin-1-yl]amino]carbonyl]oxy]ethyl]-N2-[2-[2-[2-[[3-(3-mercapto-2,5-dioxo-1-pyrrolidinyl)-1-oxopropyl]amino]ethoxy]ethoxy]acetyl]-L-glutaminyl-N-methylglycyl-N-methylglycyl-Nmethylglycyl-N-methylglycyl-N-methylglycyl-N-methylglycyl-N-methylglycyl-Nmethylglycyl-N-methylglycyl-N-methylglycine
LY-4170156
LY4170156
MBK-103
MBK103
SOFETABART MIPITECAN [USAN]
Sofetabart Mipitecan

Note

UNIIs are generated based on scientific identity characteristics using ISO 11238 data elements. UNII availability does not imply any regulatory review or approval. Synonyms and mappings are based on the best public information available at the time of publication. Please report any problems/errors associated with this data to FDA-SRS@fda.hhs.gov.

SOFETABART MIPITECAN

Synonyms and Mappings

Resources